A detailed history of Aqr Capital Management LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 23,885 shares of ALT stock, worth $208,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,885
Previous 41,379 42.28%
Holding current value
$208,754
Previous $275,000 46.91%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.5 - $8.1 $96,217 - $141,701
-17,494 Reduced 42.28%
23,885 $146,000
Q2 2024

Aug 14, 2024

SELL
$5.91 - $10.23 $114,151 - $197,592
-19,315 Reduced 31.82%
41,379 $275,000
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $498,904 - $838,184
60,694 New
60,694 $617,000
Q1 2023

May 15, 2023

BUY
$4.19 - $16.83 $90,763 - $364,571
21,662 New
21,662 $91,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $428M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.